Cost Effectiveness Analysis of Dimethyl Fumarate Versus Teriflunomide for The Treatment of Multiple Sclerosis
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.1952
https://www.valueinhealthjournal.com/article/S1098-3015(17)32286-6/fulltext
Title :
Cost Effectiveness Analysis of Dimethyl Fumarate Versus Teriflunomide for The Treatment of Multiple Sclerosis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)32286-6&doi=10.1016/j.jval.2017.08.1952
First page :
A724
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1777